par Desmedt, Christine 
;Zoppoli, Gabriele;Gundem, Gunes;Pruneri, Giancarlo;Larsimont, Denis ;Fornili, Marco;Fumagalli, Debora ;Brown, David Norman ;Rothé, Françoise ;Vincent, Delphine;Kheddoumi, Naima ;Rouas, Ghizlane;Majjaj, Samira ;Brohée, Sylvain ;Van Loo, Peter;Maisonneuve, Patrick;Salgado, Roberto;Van Brussel, Thomas;Lambrechts, Diether;Bose, Ron;Metzger, Otto;Galant, Christine;Bertucci, François;Piccart-Gebhart, Martine ;Viale, Giuseppe;Biganzoli, Elia;Campbell, Peter J;Sotiriou, Christos
Référence Journal of clinical oncology, 34, 16, page (1872-1881)
Publication Publié, 2016-06
;Zoppoli, Gabriele;Gundem, Gunes;Pruneri, Giancarlo;Larsimont, Denis ;Fornili, Marco;Fumagalli, Debora ;Brown, David Norman ;Rothé, Françoise ;Vincent, Delphine;Kheddoumi, Naima ;Rouas, Ghizlane;Majjaj, Samira ;Brohée, Sylvain ;Van Loo, Peter;Maisonneuve, Patrick;Salgado, Roberto;Van Brussel, Thomas;Lambrechts, Diether;Bose, Ron;Metzger, Otto;Galant, Christine;Bertucci, François;Piccart-Gebhart, Martine ;Viale, Giuseppe;Biganzoli, Elia;Campbell, Peter J;Sotiriou, Christos Référence Journal of clinical oncology, 34, 16, page (1872-1881)
Publication Publié, 2016-06
Article révisé par les pairs
| Résumé : | Invasive lobular breast cancer (ILBC) is the second most common histologic subtype after invasive ductal breast cancer (IDBC). Despite clinical and pathologic differences, ILBC is still treated as IDBC. We aimed to identify genomic alterations in ILBC with potential clinical implications. |
